The article then turns to recent case law developments in the Netherlands in the field of Swiss-type claims. The authors take a close look at the case of Novartis v Sun regarding indirect infringement of Swiss-type claims. They conclude the article with providing insights as to the enforcement of such European patents.
This article first appeared in IAM Life Sciences 2016, a supplement to Intellectual Asset Management, published by Globe Business Media Group – IP Division.